Abstract

13546 Background: BC Patients undergoing adjuvant dose dense chemotherapy suffer high risk of febrile neutropenia (FN) due to a shortened intertreatment interval. Primary administration of Pegfilgr...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Pegfilgrastim Use and Outcomes In Non-Hodgkin-Lymphoma Patients Receiving Chemotherapy In Clinical Practice: Combined Analysis Of The Austrian and Swiss E-Avare Studies
Wolfgang Willenbacher ... Christoph Renner
Blood | VOL. 122
Wolfgang Willenbacher, et. al.Wolfgang Willenbacher ... Christoph Renner
15 Nov 2013
The frequency of regimens associated with high risk of febrile neutropenia and the incidence of dose-limiting neutropenia among patients receiving cytotoxic therapy for malignancies: the FLAME study results
Anton V. Snegovoy ... Oxana N. Prosianikova
Journal of Modern Oncology | VOL. 25
Anton V. Snegovoy, et. al.Anton V. Snegovoy ... Oxana N. Prosianikova
10 Dec 2023
Abstract P2-08-24: Risk of chemotherapy-induced febrile neutropenia (FN) in patients with metastatic cancer of the breast or other sites not receiving colony-stimulating factor prophylaxis (CSF) in US clinical practice
Derek Weycker ... Mark Hatfield
American Journal of Cancer | VOL. 80
Derek Weycker, et. al.Derek Weycker ... Mark Hatfield
14 Feb 2020
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
M.S Aapro ... C Zielinski
European Journal of Cancer | VOL. 47
M.S Aapro, et. al.M.S Aapro ... C Zielinski
20 Nov 2010
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Deep Learning Artificial Intelligence Predicts Homologous Recombination Deficiency and Platinum Response From Histologic Slides.
Erik N Bergstrom ... Ludmil B Alexandrov
Journal of Clinical Oncology | VOL. -
Erik N Bergstrom, et. al.Erik N Bergstrom ... Ludmil B Alexandrov
31 Jul 2024
Erratum: Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials.
-
Journal of Clinical Oncology | VOL. -
--
31 Jul 2024
Reply to S. Fuji.
Mark J Levis ...
Journal of Clinical Oncology | VOL. -
Mark J Levis, et. al.Mark J Levis ...
31 Jul 2024
Efficacy and Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer.
Alessandro D Santin ... Ecaterina E Dumbrava
Journal of Clinical Oncology | VOL. -
Alessandro D Santin, et. al.Alessandro D Santin ... Ecaterina E Dumbrava
31 Jul 2024
View more papers